Clinical Trial Update: De-implementing Inhaled Nitric Oxide for Congenital Diaphragmatic Hernia [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update on de-implementing the use of inhaled nitric oxide for congenital diaphragmatic hernia, with recruitment ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Diaphragmatic Hernia

Drugs mentioned

• Inhaled nitric oxide (nitric oxide)

Snippet

Sponsor: The University of Texas Health Science Center, Houston | Conditions: Congenital Diaphragmatic Hernia | Phase 4 | Status: RECRUITING